These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3709646)

  • 1. Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approach.
    Schmidt LG; Dirschedl P; Grohmann R; Scherer J; Wunderlich O; Müller-Oerlinghausen B
    Eur J Clin Pharmacol; 1986; 30(2):199-204. PubMed ID: 3709646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of adverse drug reaction assessment in psychiatric inpatients.
    Grohmann R; Dirschedl P; Scherer J; Schmidt LG; Wunderlich O
    Eur Arch Psychiatry Neurol Sci; 1985; 235(3):158-63. PubMed ID: 2868897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions.
    Busto U; Naranjo CA; Sellers EM
    Br J Clin Pharmacol; 1982 Feb; 13(2):223-7. PubMed ID: 7059419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity.
    Hutchinson TA; Leventhal JM; Kramer MS; Karch FE; Lipman AG; Feinstein AR
    JAMA; 1979 Aug; 242(7):633-8. PubMed ID: 449003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions in a psychiatric department of tertiary care teaching hospital in India: Analysis of spontaneously reported cases.
    Patel TK; Bhabhor PH; Desai N; Shah S; Patel PB; Vatsala E; Panigrahi S
    Asian J Psychiatr; 2015 Oct; 17():42-9. PubMed ID: 26216702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AMSP drug safety program: methods and global results.
    Grohmann R; Engel RR; Rüther E; Hippius H
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S4-11. PubMed ID: 15052509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
    Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?
    Kane-Gill SL; Kirisci L; Pathak DS
    Ann Pharmacother; 2005 Nov; 39(11):1823-7. PubMed ID: 16204392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse psychic reactions to psychotropic drugs--a report from the AMUP study.
    Grohmann R; Ströbel C; Rüther E; Dirschedl P; Helmchen H; Hippius H; Müller-Oerlinghausen B; Schmidt LG; Wolf B
    Pharmacopsychiatry; 1993 May; 26(3):84-93. PubMed ID: 8415899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized comparison of six adverse drug reaction assessment procedures.
    Pere JC; Begaud B; Haramburu F; Albin H
    Clin Pharmacol Ther; 1986 Oct; 40(4):451-61. PubMed ID: 3757408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.
    Liang R; Borgundvaag B; McIntyre M; Thwaites C; Ragan K; Wyllie A
    Pharmacotherapy; 2014 Nov; 34(11):1159-66. PubMed ID: 25266970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain.
    D'Incau P; Lapeyre-Mestre M; Carvajal A; Donati M; Salado I; Rodriguez L; Sáinz M; Escudero A; Conforti A
    Fundam Clin Pharmacol; 2014 Jun; 28(3):342-8. PubMed ID: 23617454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review.
    Talat B; Mayers A; Baldwin DS
    Hum Psychopharmacol; 2013 Sep; 28(5):413-20. PubMed ID: 23754771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions and polypharmacy in the elderly in general practice.
    Veehof LJ; Stewart RE; Meyboom-de Jong B; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 1999 Sep; 55(7):533-6. PubMed ID: 10501824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-rater agreement on assessment of outcome within a trauma registry.
    Ekegren CL; Hart MJ; Brown A; Gabbe BJ
    Injury; 2016 Jan; 47(1):130-4. PubMed ID: 26304002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A targeted method for standardized assessment of adverse drug events in surgical patients.
    de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
    J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview.
    Wilson JT; Hareendran A; Hendry A; Potter J; Bone I; Muir KW
    Stroke; 2005 Apr; 36(4):777-81. PubMed ID: 15718510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs.
    Sessa M; Rafaniello C; Sportiello L; Mascolo A; Scavone C; Maccariello A; Iannaccone T; Fabrazzo M; Berrino L; Rossi F; Capuano A
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):9-15. PubMed ID: 27875917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.